Pharmacist Infectious Disease | Standard of Care | Treatment Guidelines Podcast 30 credit minutes

Corticosteroids in the treatment of community-acquired pneumonia (CAP) remain a topic of clinical curiosity and mixed opinions. In this unique episode, two expert guests share opposing perspectives—one advocating for corticosteroid use in CAP and the other urging caution—offering pharmacists a balanced view of the current evidence and practice considerations. Tune in to explore both sides of the debate and walk away with insights to inform your role in collaborative patient care.

Learning Objectives

Upon successful completion of this course, pharmacists should be able to:
1. Describe current evidence supporting and challenging the use of corticosteroids in the treatment of community-acquired pneumonia (CAP).
2. Identify key considerations for pharmacists when evaluating corticosteroid use as adjunctive therapy in CAP.

Faculty

Rachel Maynard, PharmD

GameChangers Podcast Host and Clinical Editor, CEimpact
Lead Editor, Pyrls

Disclosures:

Rachel Maynard has no relevant financial relationships to disclose.

Sam Markle, PharmD

Critical Care Pharmacist
Sanford Health

Disclosures:

Sam Markle has no relevant financial relationships to disclose.

Tristan Houle, PharmD

PGY2 Critical Care Pharmacy Resident
Sanford Health

Disclosures:

Tristan Houle has no relevant financial relationships to disclose.

Course Details